TLR4 and Cowden disease: These authors suggested that such an autoantibody detectable in active CD patients (but not in those on GFD) may bind TLR4 on monocytes and increase the expression of activation molecules (such as CD83 and CD40) and the production of pro-inflammatory mediators [55].